Is real-world evidence up to the task of gaining new indications?
Dan Danielson MS, RPh
Advertisement
Articles by Dan Danielson MS, RPh
Advertisement
Latest Updated Articles
Show Me The Data: Why Payers Need to See RWE Used in New Indication ApprovalsPublished: May 21st 2019 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
HS patients on biosimilar adalimumab lose response faster than those on the original drug
2
New self-injectable biologics promise cost savings and patient convenience
3
World AIDS Day: 10 things to know about AIDS in 2025
4
New drug class shows promise for geographic atrophy
5
